COVID-19 Research Paper Volume 14, Issue 1 pp 73—108
Decreased TMPRSS2 expression by SARS-CoV-2 predicts the poor prognosis of lung cancer patients through metabolic pathways and immune infiltration
Figure 5. DNA methylation of TMPRSS2 in LUAD. (A) Associations of DNA methylation of TMPRSS2 with clinicopathological parameters of LUAD. (B) Methylation levels of TMPRSS2 in LUAD according to the SurvivalMeth database. (C) The distribution of prognostic index in LUAD. (D) Heatmap of DNA methylation of TMPRSS2 in LUAD. (E) The prognostic potential of DNA methylation of TMPRSS2 in LUAD based on the SurvivalMeth database. *p < 0.05, **p < 0.01, ***p < 0.001.